Example: Heart Attack
Search clinical trials for: Dose decrease
Total 7787 results
-
NCT00604526Completed
-
NCT01801436Completed
-
NCT00626184Completed
-
NCT00312832Completed
-
NCT00311337Unknown
-
NCT07193628RecruitingRecurrent Glioblastoma | Refractory Glioblastoma
-
NCT03920215CompletedLong Term Follow up Dry Eye Disease
-
NCT04546347Completed
-
-
NCT03426748Active, not recruitingProstate Cancer
-
NCT05486260CompletedCancer | Malnutrition | Chemotherapy Effect | Dysgeusia | Ageusia | Hypogeusia
-
NCT03373669CompletedCholera | Vibrio Cholerae Infection
-
NCT03318731CompletedInflammation | Muscle Damage
-
NCT02472418Completed
-
NCT01214343UnknownNeoplasms | Carcinoma | Carcinoma, Hepatocellular | Liver Neoplasms | Advanced Hepatocellular Carcinoma
-
NCT00864669Completed
-
NCT06757881Active, not recruiting
-
-
NCT05553301Completed
-
NCT06078423CompletedRabies Vaccine Adverse Reaction
-
NCT04711213CompletedCataract in Inflammatory Ocular Disorders
-
NCT01324089CompletedFocus of the Study: Normal Volunteers
-
NCT07517705Not yet recruitingDiffuse Large B-Cell Lymphoma
-
NCT07443709Not yet recruiting
-
NCT07312422RecruitingPancreatic Cancer | PD-1 Inhibitor | PD-L1 | LDRT | Proterizumab
-
-
NCT06995677RecruitingFGFR Gene Amplification | FGFR3 Gene Mutation | FGFR3 Gene Alteration | FGFR Gene Alterations | FGFR3 Gene Fusions | Low-grade NMIBC
-
NCT06775756Not yet recruitingNasopharyngeal Carcinoma
-
NCT06481839Not yet recruiting
-
NCT06446713RecruitingHead and Neck Cancer | Oropharyngeal Cancer
-
NCT06220552Recruiting
-
NCT03213613Completed
-
NCT04852861Completed
-
NCT05661162Completed
-
NCT03403036Completed
-
NCT02147639CompletedBecker Muscular Dystrophy
-
NCT03321214Completed
-
NCT02953197Completed
-
NCT02311855CompletedRheumatoid Arthritis